
Healthcare · NSE / BSE
Established in 1981, Vijaya Diagnostic Centre is a leading diagnostic chain in Southern India, offering comprehensive pathology and radiology services with around 740 routine tests, 870 specialized pathology tests, 220 basic radiology tests, and 320 advanced radiology tests, along with customized health and wellness packages. The company operates 80 diagnostic centers and 11 reference laboratories across 13 cities in Telangana, Andhra Pradesh, the National Capital Region, and Kolkata, with 96.2% of revenue coming from Hyderabad and nearby regions. In the year ended March 31, 2021, Vijaya Diagnostic Centre conducted approximately 6.20 million pathology tests and 0.89 million radiology tests for about 2.63 million customers, and all its laboratories hold NABL accreditation, with three centers also holding NABH accreditation.
Price Band
₹522 – ₹531
Issue Size
₹1894 Cr
Lot Size
28 shares
GMP
-1.9%
Est. Listing
₹521
at current GMP
Subscribed
—
Open
1 Sep 2021
Close
3 Sep 2021
Allotment
8 Sep 2021
Refund
9 Sep 2021
Demat Credit
10 Sep 2021
Listing
14 Sep 2021
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹531
Band: ₹522 – ₹531
Estimated Listing Price
₹521
Upper price + GMP
Lot Size
28 shares
Min investment ₹14,868
Estimated Profit / Lot
₹0
28 × ₹-10
Grey Market Premium trend
-₹10
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | -₹10 | -1.9% | ₹521 |
| 30 Oct 2026 | -₹10 | -1.9% | ₹521 |
| 29 Oct 2026 | — | -1.7% | ₹522 |
GMP is unofficial market data. Not a guarantee of listing performance.
Vijaya Diagnostic Centre Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,894 Crores. The shares are offered at a price band of ₹522 to ₹531 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2021-09-03, the basis of allotment is scheduled to be finalized on 2021-09-08. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
The latest grey market premium for Vijaya Diagnostic Centre Limited IPO is ₹-10, which indicates an expected listing price of ₹521.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.